{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:24:29Z","timestamp":1760189069484},"reference-count":21,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T00:00:00Z","timestamp":1242345600000},"content-version":"unspecified","delay-in-days":10514,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["journals.cambridge.org"],"crossmark-restriction":true},"short-container-title":["J. Hyg."],"published-print":{"date-parts":[[1980,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>A regimen of oral non-absorbable prophylactic antibiotics (kanamycin\u2013vanco\u2013mycin\u2013nystatin) was given to nine severely neutropaenic leukaemic patients on cytotoxic therapy (11 courses), in conjunction with isolation procedures. An appreciable decrease in faecal organisms, especially anaerobes, was apparent after 48 h of commencing the course, and most bacteria had disappeared from the stool after five days. There were three episodes of septicaemia, all with enteric organisms, whilst on these antibiotics; one proved fatal. The emergence of resistance to aminoglycosides in faecal flora, notably<jats:italic>Klebsiella<\/jats:italic>, in 6\/11 courses constituted a major problem in the use of such prophylaxis.<\/jats:p>","DOI":"10.1017\/s0022172400027157","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T09:35:43Z","timestamp":1242380143000},"page":"141-151","update-policy":"http:\/\/dx.doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":13,"title":["Prophylactic non-absorbable antibiotics in leukaemic patients"],"prefix":"10.1017","volume":"85","author":[{"given":"Kathleen","family":"King","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2009,5,15]]},"reference":[{"key":"S0022172400027157_ref012","unstructured":"King K. (1979). Septicaemia in patients with haematological malignant disease. (In the Press.)"},{"key":"S0022172400027157_ref007","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.1.4.348"},{"key":"S0022172400027157_ref008","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106560"},{"key":"S0022172400027157_ref005","volume-title":"Manual for the identification of Medical Bacteria","author":"Cowan","year":"1974"},{"key":"S0022172400027157_ref019","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197805000-00005"},{"key":"S0022172400027157_ref011","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.6.958"},{"key":"S0022172400027157_ref018","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197011)26:5<1076::AID-CNCR2820260516>3.0.CO;2-D"},{"key":"S0022172400027157_ref017","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(70)90411-3"},{"key":"S0022172400027157_ref016","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.5.737"},{"key":"S0022172400027157_ref009","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-79-5-684"},{"key":"S0022172400027157_ref021","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91856-7"},{"key":"S0022172400027157_ref014","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0308-2261(21)00033-3","article-title":"Protected environment-prophylactic antibiotic programmes","volume":"5","author":"Levine","year":"1976","journal-title":"Clinical Studies in Haematology"},{"key":"S0022172400027157_ref010","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/4.4.302"},{"key":"S0022172400027157_ref003","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1968.00300060025005"},{"key":"S0022172400027157_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)90779-6"},{"key":"S0022172400027157_ref015","first-page":"57","article-title":"Analysis of studies on protected environments and prophylactic antibiotics in adult acute leukaemia","volume":"11","author":"Levine","year":"1975","journal-title":"European Journal of Cancer"},{"key":"S0022172400027157_ref002","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.15.3.455"},{"key":"S0022172400027157_ref006","article-title":"Antibiotic sensitivity testing","volume":"217","author":"Ericsson","year":"1971","journal-title":"Acta pathologica et microbiologica scandinavica"},{"key":"S0022172400027157_ref001","doi-asserted-by":"publisher","DOI":"10.3109\/00313027509082602"},{"key":"S0022172400027157_ref013","first-page":"5","article-title":"Use of oral antibiotics in protected environment units: clinical effectiveness and role in the emergence of antibiotic resistant strains","volume":"22","author":"Klastersky","year":"1974","journal-title":"Pathologie et Biologie"},{"key":"S0022172400027157_ref004","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197405000-00004"}],"container-title":["Journal of Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0022172400027157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T12:55:01Z","timestamp":1633438501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0022172400027157\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,8]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1980,8]]}},"alternative-id":["S0022172400027157"],"URL":"https:\/\/doi.org\/10.1017\/s0022172400027157","relation":{},"ISSN":["0022-1724"],"issn-type":[{"value":"0022-1724","type":"print"}],"subject":[],"published":{"date-parts":[[1980,8]]},"assertion":[{"value":"Cambridge University Press 1980","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}